Trademark Overview
On Thursday, October 16, 2025, a trademark application was filed for XIDMI with the United States Patent and Trademark Office. The USPTO has given the XIDMI trademark a serial number of 99446216. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 16, 2025. This trademark is owned by Sanofi. The XIDMI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, immune-system related, inflammatory, and neurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, rare immune-mediated, rare immune-system related, rare inflammatory, and rare neurological diseases and disorders